Overdose (disorder) - v1.0

Overdose (disorder) - v1.0

Status

Ready for implementation

Version

1.0

Descriptions:

Term

description type

Language/acceptability

Language/acceptability

Case significance

Term

description type

Language/acceptability

Language/acceptability

Case significance

[Accidental/Intentional] [course] [substance or product] overdose (disorder)

FSN

us:P

gb:P

ci

[Accidental/Intentional] [course] [substance or product] overdose

SYN

us:P

gb:P

ci

Concept model:

Attribute Group Cardinality

Attribute Cardinality

Attribute in Group Cardinality

Attribute

Value

Attribute Group Cardinality

Attribute Cardinality

Attribute in Group Cardinality

Attribute

Value

0..0

1..1

 

0..1

 

0..1

0..1

 

0..1

0..1

 

0..1

Definition status:  

Applies to:

Template Language

Link to the misaligned concept report

Overdose misaligned concept report 2021-Dec-14

Rules for generating descriptions:

  1. Apply General rules for generating descriptions for templates

Editorial guidelines for selection of Causative agent attribute value:

The following editorial guidelines apply to concepts in the International Release; editorial guidelines for concepts in national extensions may vary.

Hierarchy

Concept type

Allowed

Exception

Examples and Notes (Note: Examples are existing concepts and may not reflect the terming patterns described in the template.)

Hierarchy

Concept type

Allowed

Exception

Examples and Notes (Note: Examples are existing concepts and may not reflect the terming patterns described in the template.)

Substance

Base

yes

n/a

Example:

  • 295184007 |Morphine overdose (disorder)|

Substance

Modification

yes

yes

Concepts representing substance modifications are exceptions and may be included if the overdose profile is significantly different from the substance base.

Exception examples:

  • Liposome or lipid complex substances (e.g. 412088006 |Amphotericin B liposome (substance)|, 426490000 |Vincristine liposome (substance)|)

  • Pegylated substance (e.g. 385544005 |Pegfilgrastim (substance)|, 770965008 |Pegvaliase (substance)|)

  • Salt forms (e.g. 273948005 |Chloral hydrate (substance)|, 396063006 |Fluphenazine decanoate (substance)|)

Example:

  • 296136008 |Chloral hydrate overdose (disorder)|

  • 296213007 |Fluphenazine decanoate overdose (disorder)|

Substance

Disposition grouper

yes

n/a

Overdose concepts representing a disposition grouper should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|.

Example:

  • 297053006 |Overdose of angiotensin-converting-enzyme inhibitors (disorder)|

  • 296515004 |Opiate antagonist overdose (disorder)|

Substance

Role grouper

yes

n/a

Overdose concepts representing a role grouper should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|. Role groupers will be transitioned to the 763158003 |Medicinal product (product)| hierarchy in a future release.

Example:

  • 297006008 |Diuretic overdose (disorder)|

  • 295217003 |Non-steroidal anti-inflammatory overdose (disorder)|

Substance

Structure grouper

yes

n/a

Overdose concepts representing a structure grouper should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|.

Example:

  • 295188005 |Pethidine analog overdose (disorder)|

  • 1155996000 |Phenothiazine and/or phenothiazine derivative overdose (disorder)|

Product

Structure grouper

no

n/a

No use case has been identified for use of this concept type for modeling in this subhierarchy.

Product

Disposition grouper

no

n/a

No use case has been identified for use of this concept type for modeling in this subhierarchy.

Product

Role grouper

no

n/a

Overdose concepts representing a role grouper should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|. Role groupers will be transitioned to the 763158003 |Medicinal product (product)| hierarchy in a future release.

Product

Medicinal product-containing

no

n/a

No use case has been identified for use of this concept type for modeling in this subhierarchy.

Product

Medicinal product-only

no

n/a

No use case has been identified for use of this concept type for modeling in this subhierarchy.

Product

Medicinal product form-containing

no

n/a

No use case has been identified for use of this concept type for modeling in this subhierarchy.

Product

Medicinal product form-only

no

n/a

No use case has been identified for use of this concept type for modeling in this subhierarchy.

Product

Clinical drug

no

n/a

No use case has been identified for use of this concept type for modeling in this subhierarchy.

Comments

Copyright © 2026, SNOMED International